Inclisiran
Overview
Inclisiran is a oligonucleotide active pharmaceutical ingredient (ChEMBL CHEMBL3990033).
API suppliers (2)
Suppliers of Inclisiran evidenced by a US FDA Type II Drug Master File or an EU Certificate of Suitability (CEP). Sources: FDA DMF list, EDQM certification database.
- HANGZHOU APEXTIDE BIOMEDICAL TECHNOLOGY CO LTDChina1 active DMF
- SUZHOU OLIPHARMA CO LTDChina1 active DMF
Patent & exclusivity (US)
Per the FDA Orange Book (1 approved US product), the latest listed US patent on Inclisiran expires 25 Aug 2036 and exclusivity 12 Feb 2033. Generic API sourcing typically opens up once these lapse.
Do you supply Inclisiran? Get in front of buyers actively sourcing it.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.